Smilow Cancer Hospital

New Haven, Connecticut 06520

6 studies enrolling now · 16 studies all time

What they study most

Acute Myeloid Leukemia, Brachytherapy, Cancer, Carcinoma, Ovarian Epithelial, Endometrial Cancer, Fallopian Tube Adenocarcinoma, Fallopian Tube Neoplasms, Fallopian Tube Serous Adenocarcinoma, Family Caregivers, Follicular Lymphoma, Glioblastoma Multiforme, Glioma, Malignant

Studies at this site

• Dose-Deescalated 3-Fraction Stereotactic Body Radiotherapy For Centrally Located Lung Cancer — Recruiting now
• Evaluation of a Mobile App Program for Coping With Cancer — Recruiting now
• A Phase 2/3 Study in Adult and Adolescent Participants With SCD — Recruiting now
• Safety and Tolerability of Fb-PMT in Recurrent Glioblastoma — Recruiting now
• Unified Network for Integrated Fluid Collection at Yale — Starting soon
• Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery — Running, not enrolling
• A Phase 3 Study to Assess Efficacy and Safety of Tafasitamab Plus Lenalidomide and Rituximab Compared to Placebo Plus Lenalidomide and Rituximab in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma or Marginal Zone Lymphoma. — Running, not enrolling
• A Long-Term Follow-Up Study of Participants With Sickle Cell Disease or Transfusion Dependent β-Thalassemia Who Received EDIT-301 — Enrolling by invitation
• A Study Evaluating the Safety and Efficacy of EDIT-301 in Participants With Severe Sickle Cell Disease (RUBY) — Running, not enrolling
• A Study of ASTX660 as a Single Agent and in Combination With ASTX727 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia (AML) — Stopped early
• Dose Escalation and Efficacy Study of mRNA-2416 for Intratumoral Injection Alone and in Combination With Durvalumab for Participants With Advanced Malignancies — Stopped early
• Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma — Paused
• A Novel Tapered Applicator for Vaginal Vault Brachytherapy — Completed
• Selinexor Treatment of Refractory Myeloma — Completed
• Neoadjuvant Modified FOLFIRINOX and Stereotactic Body Radiation Therapy in Borderline Resectable Pancreatic Adenocarcinoma — Stopped early
• Improving Cancer Family Caregivers' Knowledge and Communication About Care Options — Completed